CULLINAN THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $199.0M | $168.2M |
| FY2021 | — | $425.0M | $59.8M |
| FY2022 | — | $535.0M | $156.2M |
| FY2023 | — | $453.7M | $98.4M |
| FY2024 | — | $590.3M | $83.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $199.0M | $168.2M |
| FY2021 | — | $425.0M | $59.8M |
| FY2022 | — | $535.0M | $156.2M |
| FY2023 | — | $453.7M | $98.4M |
| FY2024 | — | $590.3M | $83.0M |